483
Huvepharma Inc.Huvepharma Inc. – FDA 483, Jan 17, 2025
Record Details
Huvepharma Inc., a drug manufacturer in Saint Louis, MO, was cited for three observations during an FDA inspection. The observations relate to inadequate master production records for lot and expiry codes, failure of the quality control unit to follow procedures during stability testing, and insufficient testing of components for harmful impurities. These issues indicate significant concerns regarding quality control and manufacturing process adherence.
- Person
View Company Profile
ID · 875d9ca9-027b-4102-83fc-d5bac90bbbe1
Other documents for Huvepharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.